Capital Fund Management (CFM)’s Immunogen Inc IMGN Stock Holding History

Capital Fund Management (CFM)’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-297,985	Closed	-$8.84M	–	2344
2023 Q4	$8.84M	Buy	297,985 +233,841	+365%	+$4.66M	0.02%	840
2023 Q3	$1.02M	Buy	+64,144	New	+$1.07M	﹤0.01%	1638
2020 Q3	–	Sell	-61,271	Closed	-$282K	–	1428
2020 Q2	$282K	Buy	+61,271	New	+$261K	﹤0.01%	937
2018 Q4	–	Sell	-100,704	Closed	-$954K	–	2299
2018 Q3	$954K	Buy	+100,704	New	+$968K	0.01%	1398
2015 Q4	–	Sell	-30,300	Closed	-$291K	–	1773
2015 Q3	$291K	Buy	+30,300	New	+$443K	﹤0.01%	1221

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Capital Fund Management (CFM)'s IMGN Position: Q1 2024 in Review

Capital Fund Management (CFM) sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 297,985 shares — an estimated $8.84M sold.

Capital Fund Management (CFM) first reported a position in IMGN in Q3 2015 and held it in 5 quarters. The position peaked at $8.84M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Capital Fund Management (CFM) reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Capital Fund Management (CFM) sold 297,985 Immunogen Inc shares in Q1 2024, an estimated $8.84M.
Capital Fund Management (CFM) first reported a position in Immunogen Inc in Q3 2015 and held it in 5 quarters.
Capital Fund Management (CFM)'s Immunogen Inc position peaked at $8.84M in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2024, filed 15 May 2024.